Back
Arianne Phosphate, Inc. Vs. Structure Therapeutics, Inc. Industry Stock Comparison
Sell
28
DRRSF
Arianne Phosphate, Inc.
Last Price:
$0.16
Seasonality Move:
-1.25%
Buy
65
GPCR
Structure Therapeutics, Inc.
Last Price:
$67.04
Seasonality Move:
-40.78%
Sell
28
Arianne Phosphate, Inc. (DRRSF)
is a Sell
Is Arianne Phosphate, Inc. a Buy, Sell or Hold?
-
The current Arianne Phosphate, Inc. [DRRSF] share price is $0.15. The Score for DRRSF is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
DRRSF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
Structure Therapeutics, Inc. (GPCR)
is a Buy
Is Structure Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Structure Therapeutics, Inc. [GPCR] share price is $67.44. The Score for GPCR is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DRRSF Stock Price Chart
What is Arianne Phosphate, Inc.'s stock price today?
-
The Arianne Phosphate, Inc. share price today is $0.15The current trend is relatively stagnant and DRRSF is experiencing selling pressure, which indicates risk of future bearish movement.
GPCR Stock Price Chart
What is Structure Therapeutics, Inc.'s stock price today?
-
The Structure Therapeutics, Inc. share price today is $67.44Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing selling pressure, which indicates risk of future bearish movement.
DRRSF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 52.49 | Buy |
| Chaikin Money Flow: | -38703 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.14 - 0.16) | Buy |
| Bollinger Bands (100): | (0.11 - 0.15) | Buy |
GPCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.09 | Buy |
| Relative Strength Index (14 RSI): | 78.81 | Buy |
| Chaikin Money Flow: | -1662506 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.48 - 52.38) | Buy |
| Bollinger Bands (100): | (16.92 - 37.88) | Buy |
DRRSF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.15 | Sell |
| 20-day SMA: | 0.15 | Buy |
| 50-day SMA: | 0.15 | Buy |
| 200-day SMA: | 0.12 | Buy |
| 8-day EMA: | 0.15 | Buy |
| 20-day EMA: | 0.15 | Buy |
| 50-day EMA: | 0.14 | Buy |
| 200-day EMA: | 0.09 | Buy |
GPCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.53 | Buy |
| 20-day SMA: | 41.36 | Buy |
| 50-day SMA: | 34.58 | Buy |
| 200-day SMA: | 24.42 | Buy |
| 8-day EMA: | 55.53 | Buy |
| 20-day EMA: | 45.05 | Buy |
| 50-day EMA: | 36.57 | Buy |
| 200-day EMA: | 28.49 | Buy |
Arianne Phosphate, Inc. Earnings Growth & DRRSF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.14 per share.
Arianne Phosphate, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Structure Therapeutics, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||